Fund profile
Tickers
RYOIX, RYOAX, RYBOX, RYCFX
Fund manager
Total assets
$112.67 mm
Liabilities
$220.70 k
Net assets
$112.45 mm
Number of holdings
67.00
67 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
ABBV Abbvie Inc | 8.74 mm | 56.40 k shares | 7.77 | Common equity | Long | USA |
AMGN AMGEN Inc. | 6.61 mm | 22.95 k shares | 5.88 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals, Inc. | 4.85 mm | 11.92 k shares | 4.31 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 4.76 mm | 5.42 k shares | 4.23 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 4.73 mm | 58.42 k shares | 4.21 | Common equity | Long | USA |
MRNA Moderna Inc | 3.38 mm | 33.95 k shares | 3.00 | Common equity | Long | USA |
BIIB Biogen Inc | 3.29 mm | 12.72 k shares | 2.93 | Common equity | Long | USA |
CTVA Corteva Inc | 3.10 mm | 64.62 k shares | 2.75 | Common equity | Long | USA |
AstraZeneca plc
|
2.94 mm | 43.60 k shares | 2.61 | Common equity | Long | UK |
ILMN Illumina Inc | 2.62 mm | 18.81 k shares | 2.33 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals Inc | 2.61 mm | 13.66 k shares | 2.32 | Common equity | Long | USA |
CYTK Cytokinetics Inc | 2.28 mm | 27.32 k shares | 2.03 | Common equity | Long | USA |
BMRN Biomarin Pharmaceutical Inc. - Registered Shares | 2.23 mm | 23.10 k shares | 1.98 | Common equity | Long | USA |
EXAS Exact Sciences Corp. | 2.02 mm | 27.24 k shares | 1.79 | Common equity | Long | USA |
VTRS Viatris Inc | 1.95 mm | 180.37 k shares | 1.74 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 1.92 mm | 14.61 k shares | 1.71 | Common equity | Long | USA |
Royalty Pharma plc
|
1.92 mm | 68.42 k shares | 1.71 | Common equity | Long | USA |
INCY Incyte Corp. | 1.90 mm | 30.19 k shares | 1.69 | Common equity | Long | USA |
LEGN Legend Biotech Corp | 1.72 mm | 28.53 k shares | 1.53 | Common equity | Long | Cayman Islands |
UTHR United Therapeutics Corp | 1.57 mm | 7.16 k shares | 1.40 | Common equity | Long | USA |
SRPT Sarepta Therapeutics Inc | 1.57 mm | 16.26 k shares | 1.39 | Common equity | Long | USA |
Alkermes plc
|
1.53 mm | 55.14 k shares | 1.36 | Common equity | Long | USA |
IMGN Immunogen, Inc. | 1.47 mm | 49.43 k shares | 1.30 | Common equity | Long | USA |
EXEL Exelixis Inc | 1.46 mm | 60.87 k shares | 1.30 | Common equity | Long | USA |
NTRA Natera Inc | 1.43 mm | 22.86 k shares | 1.27 | Common equity | Long | USA |
Jazz Pharmaceuticals plc
|
1.43 mm | 11.64 k shares | 1.27 | Common equity | Long | USA |
Novocure Ltd.
|
1.43 mm | 95.85 k shares | 1.27 | Common equity | Long | USA |
ITCI Intra-Cellular Therapies Inc | 1.42 mm | 19.82 k shares | 1.26 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals Inc | 1.39 mm | 27.46 k shares | 1.24 | Common equity | Long | USA |
BNTX BioNTech SE | 1.31 mm | 12.39 k shares | 1.16 | Common equity | Long | Germany |
MEDP Medpace Holdings Inc | 1.29 mm | 4.21 k shares | 1.15 | Common equity | Long | USA |
BBIO BridgeBio Pharma Inc | 1.29 mm | 31.87 k shares | 1.14 | Common equity | Long | USA |
KRTX Karuna Therapeutics Inc | 1.27 mm | 4.03 k shares | 1.13 | Common equity | Long | USA |
ROIV Roivant Sciences Ltd | 1.24 mm | 110.14 k shares | 1.10 | Common equity | Long | USA |
ACAD Acadia Pharmaceuticals Inc | 1.20 mm | 38.46 k shares | 1.07 | Common equity | Long | USA |
BPMC Blueprint Medicines Corp | 1.20 mm | 13.05 k shares | 1.07 | Common equity | Long | USA |
APLS Apellis Pharmaceuticals Inc | 1.20 mm | 20.01 k shares | 1.06 | Common equity | Long | USA |
ARGX Argen X SE | 1.19 mm | 3.12 k shares | 1.06 | Common equity | Long | Netherlands |
RVMD Revolution Medicines Inc | 1.18 mm | 41.10 k shares | 1.05 | Common equity | Long | USA |
CRISPR Therapeutics AG
|
1.17 mm | 18.70 k shares | 1.04 | Common equity | Long | USA |
FOLD Amicus Therapeutics Inc | 1.17 mm | 82.42 k shares | 1.04 | Common equity | Long | USA |
PCVX Vaxcyte Inc | 1.17 mm | 18.58 k shares | 1.04 | Common equity | Long | USA |
INSM Insmed Inc | 1.15 mm | 37.15 k shares | 1.02 | Common equity | Long | USA |
HALO Halozyme Therapeutics Inc. | 1.09 mm | 29.46 k shares | 0.97 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 1.08 mm | 22.49 k shares | 0.96 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals Inc. | 1.03 mm | 33.82 k shares | 0.92 | Common equity | Long | USA |
MRTX Mirati Therapeutics Inc | 1.01 mm | 17.17 k shares | 0.90 | Common equity | Long | USA |
GH Guardant Health Inc | 927.36 k | 34.28 k shares | 0.82 | Common equity | Long | USA |
CFRXQ CONTRAFECT Corp | 908.83 k | 92.64 k shares | 0.81 | Common equity | Long | USA |
IMVT Immunovant Inc | 857.89 k | 20.36 k shares | 0.76 | Common equity | Long | USA |
NTLA Intellia Therapeutics Inc | 847.56 k | 27.80 k shares | 0.75 | Common equity | Long | USA |
AXSM Axsome Therapeutics Inc | 804.89 k | 10.11 k shares | 0.72 | Common equity | Long | USA |
TGTX TG Therapeutics Inc | 803.49 k | 47.04 k shares | 0.71 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics Inc | 776.25 k | 95.48 k shares | 0.69 | Common equity | Long | USA |
PTCT PTC Therapeutics Inc | 760.88 k | 27.61 k shares | 0.68 | Common equity | Long | USA |
Prothena Corporation plc
|
749.59 k | 20.63 k shares | 0.67 | Common equity | Long | USA |
DVAX Dynavax Technologies Corp. | 710.16 k | 50.80 k shares | 0.63 | Common equity | Long | USA |
IRWD Ironwood Pharmaceuticals Inc - Ordinary Shares | 677.51 k | 59.22 k shares | 0.60 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc | 668.52 k | 24.56 k shares | 0.59 | Common equity | Long | USA |
TEF Telefonica S.A | 610.18 k | 26.13 k shares | 0.54 | Common equity | Long | USA |
KRYS Krystal Biotech Inc | 574.27 k | 4.63 k shares | 0.51 | Common equity | Long | USA |
MDGL Madrigal Pharmaceuticals Inc | 566.19 k | 2.45 k shares | 0.50 | Common equity | Long | USA |
First American Government Obligations Fund - Class X | 565.55 k | 565.55 k shares | 0.50 | Short-term investment vehicle | Long | USA |
SAGE Sage Therapeutics Inc | 564.89 k | 26.07 k shares | 0.50 | Common equity | Long | USA |
NVAX Novavax, Inc. | 358.28 k | 74.64 k shares | 0.32 | Common equity | Long | USA |
J.P. Morgan Securities LLC | 126.18 k | 126.18 k principal | 0.11 | Repurchase agreement | Long | USA |
BofA Securities, Inc. | 101.69 k | 101.69 k principal | 0.09 | Repurchase agreement | Long | USA |